Brief: Rubius Therapeutics Reports Fourth Quarter And Full Year 2020 Financial Results
23/02/2021 13:10
Feb 23 (Reuters) - Rubius Therapeutics Inc RUBY.O :
* RUBIUS THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2020
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* Q4 LOSS PER SHARE $0.50
* Q4 EARNINGS PER SHARE ESTIMATE $-0.50 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNX7Pk4jS
Further company coverage: RUBY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rubius Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Apple, TCR2 Therapeutics, Silvergate Capital
Brief: Rubius Therapeutics Inc - Nasdaq Notified Co That Trading In Co's Stock Will Be Suspended Upon Opening Of Business On March 7, 2023
Brief: Rubius Therapeutics Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Rubius Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Baidu, Boeing, Microsoft